Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...

Narcotics research, rehabilitation, and treatment. Hearings, Ninety ... Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...

library.whnlive.com
from library.whnlive.com More from this publisher
12.07.2015 Views

directordirector—:518Inlernship.—Sinai Hopital, Baltimore, Md., 1940-41.Military service.—In the Armed Forces from 1941 to 1946. Positions heldBattalion surgeon: Office of the psychiatric service of the Valley Forge GeneralHospital. Attended the Arm.y School of ^Military Neuropsychiatry at the MasonGeneral Hospital. Awarded the Legion of Merit and the Combat Medical Badge.Special training.-— Electroencephalography CArmy— 1945), research fellowshipin neuropsychiatry (Sinai Hosj^ital, Baltimore, Md., 1946-47), personal analysisand attended courses at the Baltimore- Washington Psychoanalytic Institute(1947-49).Positions held.-—Psychiatrist part time in the mental hygiene clinic of theBaltimore Regional Office, Veterans' Administration (1947-49) ; staff psychiatrist.Spring Grove State Hospital, Catonsville, Md. (1949-53) : psychiatric consultant.Fort George G. Meade, Maryland State Hospital (1950-51) ;psychiatric consultant,Aberdeen Proving Grounds, Maryland Station Hospital (1951-52);director of medical research. Spring Grove State Hospital, Catonsville, Md.(1953-60) ; of research. Friends of Psychiatric Research, Inc., Catonsville,Md. (1953 to present) ; of research, Maryland State Department ofMental Hygiene (1960-67) ; director, Maryland State Psychiatric Research Center,(1967-) ; assistant commissioner for research, Maryland State Department ofMental Hygiene (1967-).Certification.—In psychiatry by the American Board of Neurology and Psychiatry,1951. Fellow of the American Psychiatric Association, 1955.Societies.— American Medical Association, American Psj-chiatric Association,Collegium Internationale Neuro-Psycho Pharmacologicum, Societ}^ for Psj'chophysiologicalResearch, member, Council on Medical Television.Societies.— Member, American College of Neurophyshopharmacology; member,the Maryland Society for Medical Research: member, NIMH, Committee onClinical Drug Evaluation of the Psvchopharmacology Service Center (July 1,1963, to June 30, 1967)).Research publications.—A total of approximately 150 have been publi.shed overthe past 30 years.Specific publications in the area of narcotic research up to the present time (10)Laboratory Control in the Treatment of the Narcotic Addict : Kurland, A. A.,Ibanez, Ricardo, and Derby, I. M. Presented at 24th Annual Meeting ofCommittee on Drug Addiction and Narcotics, National Academy of Sciences,Washington, D.C., January 30, 1962.A Practical Application of Thin-Layer Chromatography in Urinalysis for theDetection of Narcotic Drugs: Kurland, A. A., Kolvoski, R. J. Presentedat third annual meeting of .\CNP, San Juan, P.R., December 15, 1965.Urine Detection Tests in the Management of the Narcotic Addict: Kurland,A. A., Wurmser, L., Kerman F. and Kokoski, R. J. .\mer. J. Psvchiat.,122: Jan. 1966.The Narcotic Addict—Some Reflections on Treatment: Kurland, A. A.Maryland State Medical Journal, March 1966.Laboratory Control in the Treatment of the Narcotic Addict: Kurland, A. A.,Wurmser, L., and Kokoski, R. J. Curr. Psvchiat. Ther., volume 6: 243-246, 1966.Intermittent Patterns of Narcotic Usage: Kurland, A. A., Kerman, F.,Wurmser, L., and Kokoski, R. J. Presented at fourth annual meeting ofACNP, Puerto Rico, December 9, 1966.The Deterrent Effect of Dailv Urine Analysis for Opiates in a NarcoticOut-Patient Facility—A Two and One-half Year Study: Kurland, A. A.,Wurmser, L., Kerman, F., and Kokoski, R. J. Presented at annual meeting.NAS, Committee on Drug Addiction, Lexington, Ky., February 16,1967.Narcotic Detection by Thin-La.ver Chromatography in a Urine ScreeningProgram: Kokoski, R. J., Waitsman, E. S., Sands, F. L., and Kurland,A. A. Presented at annual meeting. NAS, Committee on Problems ofDrug Denendence, Indianapolis, Ind., February 21, 196S.Morphine Detection by Thin-Layer Chromotography in a Urine ScreeningProgram: A comparison of ion exchange resin loaded paper extraction withdirect solvent extraction: Kokoski, R. J., Sands, F. L., and Kurland, A. A.Presented at 31st aiuiual meeting of the Committee on Problems of DrugDependence, NAS-NRC, Palo Alto, Calif., Feb. 2.5-26, 1969.The Out-Patient ManagerncTit of the Paroled Narcotic .\buser—A 4- YearEvaluation: Kurland, A. A., Bass, G. A., Kerman, F., and Kokoski. R. J.Presented at 31st annual meeting of the Committee on Problems of DrugDependence, NAS-NRC, Palo Alto, Calif., Feb. 25-26, 1969.

519The Deceptive Communication and the Narcotic Abuser: Kurland, A. A.Rutgers Symposium on Comnnmication and Drug Abuse, Sept. 3-5, 1969.Rutgers University, The State University of New Jersey, New Brunswick,N.J.The Out-Patient Management of the Narcotic Addict: Kurland, A. A. InPerry Bhick (Ed.) Drugs and the Brain. Baltimore, Md.: The JohnsHopkins Press, 1969, pp. 363-370.The Daily Testing of Urine for Opiates as a Deterrent to Opiate Usage. TheResults of a .VYear Study: Kurland, A. A., Kokoski, R., Kerman, F., andBass, G. A. Presented at 32d annual meeting of the Committee on Problemsof Drug Dependence, NAS-NRC, Washington, D.C., Feb. 16-18,1970. (Published in 1970 Report, pp. 6719-6730.)N-allyl-14-hydroxydihydronormorphinone (Naloxone) in the Management ofthe Narcotic Abuser. A Pilot Study: Kurland, A. A., and Kermai, F.Presented at the 33d annual meeting of the Committee on Problems ofDrug Dependence, NAS-NRC, Toronto, Ontario, Canada, Feb. 16-17,1971.Attachment No. 2[Reprinted Froui the American Journal of P.sychiatr.v. vol. 122. No. 7, January 1966]Urine Detection Tests in the Man.\gement of the Narcotic Addict(By Albert A. Kurland, M.D., Leon Wurmser, M.D., Frances Kerman, R.N.,and Robert Kokoski, Ph. D.)The focus of this study was the data originating from the daily analysis of urineof narcotic users being treated in an inpatient and outpatient setting. This informationhas provided impressions suggesting certain treatment approaches whichmay provide for their more effectiv-e management. The inpatient group was madeup of court-referred narcotic addicts and patients seeking voluntary admission tothe Spring Grove State Hospital because of narcotic addiction. The outpatientgroup was made up of parolees from the correctional institutions of Maryland whohad been penalized for their use of narcotics.The background and history of the role of laboratory control in the supervision ofthe narcotic addict are relatively brief. Until 10 years ago the only means availableto the clinician for ascertaining the addict's use of narcotics were his clinicalobservations and complex, time-consuming laboratory procedures for analyzingurine for narcotics.The introduction in California of nalorphine testing (the measurement of apupillary response following the administration of a single dose of this drug) inI9r)~) as a medicolegal procedure in testing convicted narcotic users on parole orprobation to determine their abstinence from narcotics opened up a new approachin the attempts to control the ingestion of narcotic drugs (5, 6, 7). By 1962, over6,000 nalorphine injections were being administered per month (9, 10). The testwill yield a negative result if it has been preceded by a drug-free period of 24 to 48hours, or if a drug that produces a dilatation of the pupil has been administeredprior to the test procedure. Also, the test is not as accurate or sensitive as chemicaltests for narcotics in urine (•?, 4). Nevertheless, nalorphine testing was thought tobe useful by the parole and probation officers (.9, 10). It was their impression thatalthough the potential for addiction remains, the problem is contained. However,Terry and Teixeira {10) were not able to make a conclusive statement on thiswhen they summarized their impressions in 1962 after having observed the use ofthe test in California for several years.METHODOur own experience with the management of the narcotic addict began in 1960with court-referred narcotic addicts who came to the hospital for diagnostic studyand treatment. In an effort to determine the patient's receptivity toward treatment,we attempted to determine his freedom from narcotics on a daily basis.For this purpose nalorphine testing was not feasible, but a spot test for narcoticsin urine was employed. This procedure, the Motley spot test {8), was accepted asbeing neither sensitive nor specifically reliable. However, the test was helpful inalerting the hospital staff to possible breaches of abstinence and emphasized theusefulness of this type of assessment. In January 1964, the Motley test was

519The Deceptive Communication <strong>and</strong> the Narcotic Abuser: Kurl<strong>and</strong>, A. A.Rutgers Symposium on Comnnmication <strong>and</strong> Drug Abuse, Sept. 3-5, 1969.Rutgers University, The State University of New Jersey, New Brunswick,N.J.The Out-Patient Management of the Narcotic Addict: Kurl<strong>and</strong>, A. A. InPerry Bhick (Ed.) Drugs <strong>and</strong> the Brain. Baltimore, Md.: The JohnsHopkins Press, 1969, pp. 363-370.The Daily Testing of Urine for Opiates as a Deterrent to Opiate Usage. TheResults of a .VYear Study: Kurl<strong>and</strong>, A. A., Kokoski, R., Kerman, F., <strong>and</strong>Bass, G. A. Presented at 32d annual meeting of the Committee on Problemsof Drug Dependence, NAS-NRC, Washington, D.C., Feb. 16-18,1970. (Published in 1970 Report, pp. 6719-6730.)N-allyl-14-hydroxydihydronormorphinone (Naloxone) in the Management ofthe Narcotic Abuser. A Pilot Study: Kurl<strong>and</strong>, A. A., <strong>and</strong> Kermai, F.Presented at the 33d annual meeting of the Committee on Problems ofDrug Dependence, NAS-NRC, Toronto, Ontario, Canada, Feb. 16-17,1971.Attachment No. 2[Reprinted Froui the American Journal of P.sychiatr.v. vol. 122. No. 7, January 1966]Urine Detection Tests in the Man.\gement of the Narcotic Addict(By Albert A. Kurl<strong>and</strong>, M.D., Leon Wurmser, M.D., Frances Kerman, R.N.,<strong>and</strong> Robert Kokoski, Ph. D.)The focus of this study was the data originating from the daily analysis of urineof narcotic users being treated in an inpatient <strong>and</strong> outpatient setting. This informationhas provided impressions suggesting certain <strong>treatment</strong> approaches whichmay provide for their more effectiv-e management. The inpatient group was madeup of court-referred narcotic addicts <strong>and</strong> patients seeking voluntary admission tothe Spring Grove State Hospital because of narcotic addiction. The outpatientgroup was made up of parolees from the correctional institutions of Maryl<strong>and</strong> whohad been penalized for their use of narcotics.The background <strong>and</strong> history of the role of laboratory control in the supervision ofthe narcotic addict are relatively brief. Until 10 years ago the only means availableto the clinician for ascertaining the addict's use of narcotics were his clinicalobservations <strong>and</strong> complex, time-consuming laboratory procedures for analyzingurine for narcotics.The introduction in California of nalorphine testing (the measurement of apupillary response following the administration of a single dose of this drug) inI9r)~) as a medicolegal procedure in testing convicted narcotic users on parole orprobation to determine their abstinence from narcotics opened up a new approachin the attempts to control the ingestion of narcotic drugs (5, 6, 7). By 1962, over6,000 nalorphine injections were being administered per month (9, 10). The testwill yield a negative result if it has been preceded by a drug-free period of 24 to 48hours, or if a drug that produces a dilatation of the pupil has been administeredprior to the test procedure. Also, the test is not as accurate or sensitive as chemicaltests for narcotics in urine (•?, 4). Nevertheless, nalorphine testing was thought tobe useful by the parole <strong>and</strong> probation officers (.9, 10). It was their impression thatalthough the potential for addiction remains, the problem is contained. However,Terry <strong>and</strong> Teixeira {10) were not able to make a conclusive statement on thiswhen they summarized their impressions in 1962 after having observed the use ofthe test in California for several years.METHODOur own experience with the management of the narcotic addict began in 1960with court-referred narcotic addicts who came to the hospital for diagnostic study<strong>and</strong> <strong>treatment</strong>. In an effort to determine the patient's receptivity toward <strong>treatment</strong>,we attempted to determine his freedom from narcotics on a daily basis.For this purpose nalorphine testing was not feasible, but a spot test for narcoticsin urine was employed. This procedure, the Motley spot test {8), was accepted asbeing neither sensitive nor specifically reliable. However, the test was helpful inalerting the hospital staff to possible breaches of abstinence <strong>and</strong> emphasized theusefulness of this type of assessment. In January 1964, the Motley test was

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!